Features of essential thrombocythemia in newborns and infants

Read full text Summarise with VIRAT
Authors: L. D. Akhverdieva, D. M. Muscherova, H. A. Sarkisyan, S.V. Cherkasova, M. V. Dragunova, P.V. Shumilov
Cited by: 0
References: 30

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Essential thrombocythemia (ICD-10: D47.3, OMIM: #187950) is a rare clonal myeloproliferative disorder characterized by a persistent increase in platelet count. The clinical course in newborns and young children is predominantly asymptomatic or oligosymptomatic, with a paradoxically low risk of thrombotic complications against a background of a high frequency of microvascular and haemorrhagic disorders caused by acquired von Willebrand syndrome. The diagnosis of essential thrombocythemia is complicated by the need to exclude reactive thrombocytosis and its hereditary forms, which are more common in the neonatal period. A promising direction at the moment is the development of paediatric diagnostic criteria and comprehensive genetic analyses to identify new driver mutations. Treatment is conservative and often leads to a favourable outcome. This review systematises current data from the world literature on the characteristics of essential thrombocythemia in newborns and young children, focusing on key differences from the adult form of the disease.

Fields of Study & Subjects

Myeloproliferative Neoplasms: Diagnosis and Treatment Platelet Disorders and Treatments Autoimmune and Inflammatory Disorders Research

Publication details

Journal / source
CHILDREN INFECTIONS
Volume
25
Issue
1
Pages
53–59
Publication date
27 March 2026
Language
EN